Increased ACE and decreased ACE2 expression in kidneys from patients with IgA nephropathy

Nephron - Clinical Practice

Volumn 117, Issue 1, 2010, Pages

  Mizuiri, Sonoo ^a   Hemmi, Hiromichi ^a   Arita, Michitsune ^a   Aoki, Toshiyuki ^a   Ohashi, Yasushi ^a   Miyagi, Moriatsu ^a   Sakai, Ken ^a   Shibuya, Kazutoshi ^a   Hase, Hiroki ^b   Aikawa, Atsushi ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

Author keywords

Angiotensin converting enzyme; Angiotensin converting enzyme 2; IgA nephropathy; Immunohistochemistry; In situ hybridization; Kidney biopsy

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; DISEASE CONTROL; ENZYME LOCALIZATION; FEMALE; GENE EXPRESSION; GLOMERULUS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE NEPHROTIC SYNDROME; NEPHROTIC SYNDROME; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

ADULT; FEMALE; GENE EXPRESSION; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; PEPTIDYL-DIPEPTIDASE A; PROTEINURIA; RETROSPECTIVE STUDIES; RNA, MESSENGER; SERUM ALBUMIN; STATISTICS, NONPARAMETRIC;

EID: 77955098970     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319648     Document Type: Article

References (31)

1. Pozzi C, Del Vecchio L, Casartelli D, Pozzoni P, Andrulli S, Amore A, Peruzzi L, Coppo R, Locatelli F: ACE inhibitors and angiotensin II receptor blockers in IgA nephropathy with mild proteinuria: the ACEARB study. J Nephrol 2006; 19: 508-514.
2. Rüster C, Wolf G: Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol 2006; 17: 2985-2991.
3. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S: A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000; 87:E1-E9.
4. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ: A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000; 275: 33238-33243.
5. Burns KD: The emerging role of angiotensin- converting enzyme-2 in the kidney. Curr Opin Nephrol Hypertens 2007; 16: 116-121.
6. Burrell LM, Johnston CI, Tikellis C, Cooper ME: ACE2, a new regulator of the renin-angiotensin system. Trends Endocrinol 2004; 15: 166-169.
7. Ferrario CM, Trask AJ, Jessup JA: Advances in biochemical and functional roles of angiotensin- converting enzyme 2 and angiotensin-( 1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 2005; 289:H2281-H2290.
8. Ingelfinger JR: Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease. Curr Opin Nephrol Hypertens 2009; 18: 79-84.
9. Mizuiri S, Hemmi H, Arita M, Ohasi Y, Tanaka Y, Miyagi M, Sakai K, Ishikawa Y, Shibuya K, Hase H, Aikawa A: Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls. Am J Kidney Dis 2008; 51: 613-623.
10. Reich HN, Oudit GY, Penninger JM, Scholey JW, Herzenberg AM: Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int 2008; 74: 1610-1616.
11. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
12. Wakai K, Kawamura T, Endoh M, Kojima M, Tomino Y, Tamakoshi A, Ohno Y, Inaba Y, Sakai H: A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study. Nephrol Dial Transplant 2006; 21: 2800-2808.
13. Miyake-Ogawa C, Miyazaki M, Abe K, Harada T, Ozono Y, Sakai H, Koji T, Kohno S: Tissue-specific expression of renin- angiotensin system components in IgA nephropathy. Am J Nephrol 2005; 25: 1-12.
14. He L, Ding Y, Zhang Q, Che X, He Y, Shen H, Wang H, Li Z, Zhao L, Geng J, Deng Y, Yang L, Li J, Cai J, Qiu L, Wen K, Xu X, Jiang S: Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J Pathol 2006; 210: 288-297.
15. Mezzano S, Droguett A, Burgos ME, Ardiles LG, Flores CA, Aros CA, Caorsi I, Vío CP, Ruiz-Ortega M, Egido J: Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int 2003; 64:S64-S70.
16. Del Prete D, Gambaro G, Lupo A, Anglani F, Brezzi B, Magistroni R, Graziotto R, Furci L, Modena F, Bernich P, Albertazzi A, D'Angelo A, Maschio G: Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int 2003; 64: 149-159.
17. Takamatsu M, Urushihara M, Kondo S, Shimizu M, Morioka T, Oite T, Kobori H, Kagami S: Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy. Pediatr Nephrol 2008; 23: 1257-1267.
18. Lely AT, Hamming I, van Goor H, Navis GJ: Renal ACE2 expression in human kidney disease. J Pathol 2004; 204: 587-593.
19. Tikellis C, Johnston CI, Forbes JM, Burns WC, Burrell LM, Risvanis J, Cooper ME: Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 2003; 41: 392-397.
20. Jessup JA, Gallagher PE, Averill DB, Brosnihan KB, Tallant EA, Chappell MC, Ferrario CM: Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats. Am J Physiol Heart Circ Physiol 2006; 291:H2166-H2172.
21. Wong DW, Oudit GY, Reich H, Kassiri Z, Zhou J, Liu QC, Backx PH, Penninger JM, Herzenberg AM, Scholey JW: Loss of angiotensin- converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 2007; 171: 438-451.
22. Ye M, Wysocki J, William J, Soler MJ, Cokic I, Battle D: Glomerular localization and expression of angiotensin-converting enzyme and angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 2006; 17: 3067-3075.
23. Soler MJ, Wysocki J, Ye M, Llovrras J, Kanwar Y, Battle D: ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocininduced diabetic mice. Kidney Int 2007; 72: 614-623.
24. Largo R, Gómez-Garre D, Soto K, Marrón B, Blanco J, Gazapo RM, Plaza JJ, Egido J: Angiotensin- converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertension 1999; 33: 732-739.
25. Takase O, Marumo T, Imai N, Hirahashi J, Takayanagi A, Hishikawa K, Hayashi M, Shimizu N, Fujita T, Saruta T: NF-K B-dependent increase in intrarenal angiotensin II induced by proteinuria. Kidney Int 2005; 68: 464-473.
26. Liu BC, Gao J, Li Q, Xu LM: Albumin caused the increasing production of angiotensin II due to the dysregulation of ACE/ACE2 expression in HK2 cells. Clin Chim Acta 2009; 403: 23-30.
27. Wakahara S, Konoshita T, Mizuno S, Motomura M, Aoyama C, Makino Y, Kato N, Koni I, Miyamori I: Synergistic expression of ACE and ACE2 in human renal tissue and confounding effects of hypertension on the ACE/ACE2 ratio. Endocrinology 2007; 148: 2453-2457.
28. Wysocki J, Ye M, Soler MJ Gurley SB, Xiao HD, Bernstein KE, Coffman TM, Chen S, Batlle D: ACE and ACE2 activity in diabetic mice. Diabetes 2006; 55: 2132-2139.
29. Moon JY, Jeong KH, Lee SH, Lee TW, Ihm CG, Lim SJ: Renal ACE and ACE2 expression in early diabetic rats. Nephron Exp Nephrol 2008; 110:e8-e16.
30. Wang G, Lai FM, Lai KB Chow KM, Kwan CH, Li KT, Szeto CC: Discrepancy between intrarenal messenger RNA and protein expression of ACE and ACE2 in human diabetic nephropathy. Am J Nephrol 2009; 29: 524-531.
31. Kaplan NM: Pharmacologic therapy; in Brady HR, Wilcox CS (eds): Therapy in Nephrology and Hypertension. Philadelphia, Saunders, 1999, pp 397-403.